Drawing for CONCERTO

USPTO serial 75798573

CONCERTO

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BUSH, KAREN K
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CONCERTO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

MICHAEL J. STRIKER

MICHAEL J STRIKER103 E NECK RDHUNTINGTON, NY 11743UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical for scientific research use, namely, reagents used for in-vitro diagnostic methodsACTIVE—
005Pharmaceutical and veterinary medical goods, in particular for in-vitro diagnostics, i.e. for diagnosis of endocrine diseases, status of the immune system, bone metabolism and drug monitoringACTIVE—
009Data processing equipment and software for performing diagnostic tests in the medical and scientific field, namely, equipment and software for the control of semi-or full-automated diagnostic analyzers and for in-vitro diagnostic related data reductionACTIVE—
010Instruments, apparatuses, and devices for performing in-vitro diagnostic tests in the medical and scientific field, namely, semi- or full-automated diagnostic analyers , i.e. including liquid handling systems (pipetting robots/dispensing and aspirating systems), incubation areas and detection systems for typical diagnostic label-technologiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 22, 2003ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 20, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 11, 2000CNSLLETTER OF SUSPENSION MAILED—
Apr 10, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 10, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 10, 2000DOCKASSIGNED TO EXAMINER—
Dec 29, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance